ArticleNaunyn-Schmiedeberg's archives of pharmacology2021

Blockade of TGF-βR improves the efficacy of doxorubicin by modulating the tumor cell motility and affecting the immune cells in a melanoma model.

Alireza Mardomi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.